<i>In Vitro</i> Modeling of Cytokine-Drug Interactions Using Micropatterned Co-Cultures Of Primary Hepatocytes and Kupffer Macrophages
21 May 2014Better predictive models for iDILI would enable the preclinical elimination of drug candidates with hepatotoxic liabilities. This poster describes a method in which HepatoPac co-cultures are supplemented with primary Kupffer macrophages for use in evaluating cytokine- drug interactions. Drug- induced stresses may interact with cytokine signaling to cause hepatotoxciity.
Related Products
Request Quote for All Products
Human HepatoPac™ Kits
Hepregen CorporationHuman HepatoPac™ kits are an ideal way to conduct all your DMPK, Predictive Toxicology & Mechanistic Toxicology applications. Begin dosing as early as 3 days after receiving the kit! Use our Human HepatoPac™ Triple Donor plates for the ultimate in convenience. HepatoPac™ co-cultures derived from 3 independent and highly characterized donors are provided on a single plate (8-wells from each donor).HepatoPac™ kits can be used for any assay that can be run using sandwich, monoculture plates or suspension cultures. Due to the extended in vitro functionality of HepatoPac™ co-cultures, Hepregen kits enable studies such as low turnover clearance or chronic toxicity studies that could not otherwise be performed.Human HepatoPac™ Kits Features: HT-ready format; 24- and 96-well plates Proprietary micropatterened co-culture Superior data for both slowly and rapidly metabolized drugs Culture longevity of up to 4 weeks Kits contain: Human HepatoPac™ Co-Cultures Maintenance Media Application-specific Media and additives Instructions for culture maintenance and application-specific protocols On-site customer training included